Cita APA

Cahn, P. E., & Arribas López, J. R. (2022). Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with hiv-1 infection.

Citación estilo Chicago

Cahn, Pedro E., y José Ramón Arribas López. Three-year Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Therapy - Naive Adults With Hiv-1 Infection. 2022.

Cita MLA

Cahn, Pedro E., y José Ramón Arribas López. Three-year Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Therapy - Naive Adults With Hiv-1 Infection. 2022.